Leffler Eugene Frederick
Transaction: 07/28/2026
SELL
Change
-31,250
Price
Not reported
Filing
07/29/2026
Type
SELL
Biofrontera Inc.
BFRI • Medical - Pharmaceuticals
$1.61
▲ +0.10 (+6.62%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$19.81M
Growth
-32.4%
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.59Healthy liquidity · 1.52Negative growth trendWeak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 14, 2026, 12:36 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$1.61
Change6.62%
Shares Out12.31M
Market Cap$19.81M
Enterprise Value$19.77M
52W Range0.56 - 1.40
Beta0.80
P/E-3.11
P/S0.43
P/B3.33
P/FCF-2.50
EV/Sales0.43
Price$1.61
Change6.62%
Shares Out12.31M
Market Cap$19.81M
Enterprise Value$19.77M
52W Range0.56 - 1.40
Beta0.80
P/E-3.11
P/S0.43
P/B3.33
P/FCF-2.50
EV/Sales0.43
EV/EBITDA-5.02
EV/FCF-2.49
Earnings Yield-32.12%
FCF Yield-40.02%
Dividend Yield0.00%
Gross Margin78.65%
Oper. Margin-21.94%
Profit Margin-25.26%
Debt/Eq0.59
Current Ratio1.52
Quick Ratio1.40
Revenue 5Y-32.44%
Volume1.09M
Avg Volume265.89K
EPS Surprise-0.23
Investment DNA
How strong this company looks for long-term investors
41
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
67/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
95/100
Why this score▼
Manageable debt level · 0.59Healthy liquidity · 1.52Negative growth trendWeak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 1 analyst votes · 2026-09-05
100/100
Bullish
Bullish
1
Hold
0
Bearish
0
Insider Transactions
Recent executive and insider activity
⚠ 1 high-volume insider sell detected
Leffler Eugene Frederick
Transaction: 07/28/2026
BUY
Change
+31,250
Price
Not reported
Filing
07/29/2026
Type
BUY
Luebbert Hermann
Transaction: 07/28/2026
SELL
Change
-62,500
Price
Not reported
Filing
07/29/2026
Type
SELL
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Leffler Eugene Frederick | SELL | -31,250 | Not reported | 07/28/2026 | 07/29/2026 |
| Leffler Eugene Frederick | BUY | +31,250 | Not reported | 07/28/2026 | 07/29/2026 |
| Luebbert Hermann | SELL | -62,500 | Not reported | 07/28/2026 | 07/29/2026 |
| Luebbert Hermann | BUY | +62,500 | Not reported | 07/28/2026 | 07/29/2026 |
| Leffler Eugene Frederick | SELL | -87,500 | Not reported | 03/05/2026 | 03/06/2026 |
| Leffler Eugene Frederick | BUY | +87,500 | Not reported | 03/05/2026 | 03/06/2026 |
| Luebbert Hermann | SELL | -137,500 | Not reported | 03/05/2026 | 03/06/2026 |
| Luebbert Hermann | BUY | +137,500 | Not reported | 03/05/2026 | 03/06/2026 |
| BORER JOHN J III | BUY | +20,000 | $0.90 | 03/04/2026 | 03/06/2026 |
| Jones George Patrick | BUY | +50,000 | $0.90 | 03/04/2026 | 03/06/2026 |
| Jones George Patrick | BUY | +50,000 | Not reported | 03/04/2026 | 03/06/2026 |
| Hoffman Beth J. | BUY | +20,000 | $0.90 | 03/04/2026 | 03/06/2026 |
| Lanckriet Heikki | BUY | +20,000 | $0.90 | 03/04/2026 | 03/06/2026 |
| Leffler Eugene Frederick | BUY | +62,500 | $0.90 | 03/04/2026 | 03/06/2026 |
| Leffler Eugene Frederick | BUY | +62,500 | Not reported | 03/04/2026 | 03/06/2026 |
| Luebbert Hermann | BUY | +125,000 | $0.90 | 03/04/2026 | 03/06/2026 |
| Luebbert Hermann | BUY | +125,000 | Not reported | 03/04/2026 | 03/06/2026 |
| Weber Kevin Daniel | BUY | +20,000 | $0.90 | 03/04/2026 | 03/06/2026 |
| Plaggemars Hansjoerg | OTHER | 0 | Not reported | 09/16/2025 | 09/30/2025 |
| DELPHI UNTERNEHMENSBERATUNG AKTIENGESELLSCHAFT | OTHER | +4,831,172 | $0.62 | 09/16/2025 | 09/30/2025 |